Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576))

J. E. Cortes, H. M. Kantarjian, T. H. Brümmendorf

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalBlood
Volume122
Issue number14
DOIs
StatePublished - Oct 3 2013
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

@article{317c4fee165a455488c885164918587c,
title = "Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576))",
author = "Cortes, {J. E.} and Kantarjian, {H. M.} and Br{\"u}mmendorf, {T. H.}",
year = "2013",
month = "10",
day = "3",
doi = "10.1182/blood-2013-08-524256",
language = "English (US)",
volume = "122",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "14",

}

TY - JOUR

T1 - Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib (Blood (2011) 118, 17 (4567-4576))

AU - Cortes, J. E.

AU - Kantarjian, H. M.

AU - Brümmendorf, T. H.

PY - 2013/10/3

Y1 - 2013/10/3

UR - http://www.scopus.com/inward/record.url?scp=84888032225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888032225&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-08-524256

DO - 10.1182/blood-2013-08-524256

M3 - Comment/debate

AN - SCOPUS:84888032225

VL - 122

JO - Blood

JF - Blood

SN - 0006-4971

IS - 14

ER -